The global at-home testing market is expected to enjoy a valuation of US$ 7.1 billion in 2022, and further expand at a CAGR of 4.0% to reach a valuation of US$ 10.5 billion by the end of the year 2032. According to a recent study by Future Market Insights, digital monitoring system products are leading the market with a share of about 46.7% in the year 2021, within the global at-home testing market.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 7.1 billion |
Market Value 2032 | US$ 10.5 billion |
CAGR 2022 to 2032 | 4.0% |
Market Share of Top 5 Countries | 55.5% |
Key Market Players | Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA., Everlywell, and LetsgetChecked. |
The at-home testing market has gained popularity recently due to the numerous new alternatives it has provided for patients. They aid in the continuous monitoring of health issues, such as blood sugar and cholesterol levels, as well as the diagnosis and treatment of new patients who test positive for specific indications.
With at-home testing kits being well accepted in the market, manufacturers have seized the opportunity to offer novel kits for the well-being of patients suffering from chronic disorders, as well as in the management of several ailments.
One of the primary reasons for the market's predicted opportunistic expansion is the flexibility it affords to the self-testing audience. The rising usage of opioids and drug abuse testing has opened up new opportunities in the pain management area.
With so many brands of at-home testing kits available in the market, the FDA has set up certain regulations, including a warning about not using pre-used test strips, on 21 June 2022. It has also set up a website enlisting all the approved home tests.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for at-home testing products was approximately 5.8% of the overall ~US$ 118.5 billion of the global in-vitro diagnostics market in 2021.
The at-home testing industry has drawn a lot of attention since it offers a highly convenient way to conduct tests from the comfort of one's own home. Market players are taking advantage of this opportunity to expand their businesses and branch out into other areas
The at-home market is predicted to grow throughout the forecast period, because of the increase in business development tactics such as collaboration and acquisition by leading industry players.
For instance, Viatris Inc along with Atomo Diagnostics Limited collaborated with the globally renounced health agency Unit Aid, in the year of April 2021, to make HIV testing kits more accessible in developing countries.
Another promising reason for the lucrative growth of the market is the increasing popularity of self-testing kits among consumers . Pregnancy self-tests and blood glucose self-testing have gained so much popularity through extensive marketing that they have now become routine and useful for consumers.
To ensure the efficacy of norms, the entire regulatory landscape in the self-testing business is continually altering. In-vitro diagnostic medical devices (IVD) regulations for self-testing kits are in effect in the United States.
Owing to the aforementioned factors, the at-home testing market is expected to grow at a CAGR of 4.0% during the forecast period from 2022 to 2032.
The market is set to present an opportunistic outlook, due to technological developments in sample collection and manufacturers' efforts to develop easy-to-use disposable test kits.
These test kits use sweat, semen, and even hair samples for giving test results, which sometimes the consumer is not comfortable giving in public. At-home testing kits have made this more accessible for consumers. People can be tested easily for fertility checks and even drug abuse.
The growth will further be propelled by the adoption of self-testing policies encouraging the use of self-diagnostic kits. Developed countries are enacting self-testing policies and developing self-testing guidelines.
According to the WHO, around 41 countries have implemented HIV self-testing policies. Many countries have similar policies in place for Hepatitis B and C.
With the implementation of such government laws, the general population is encouraged to utilize self-diagnostic kits, creating significant chances for the at-home testing market to flourish.
Despite the fact that the at-home testing market includes multiple end-uses, certain challenges are expected to impede market expansion. The price increase for at-home testing kits will be a setback for this sector. Self-testing policies and recommendations are being developed in developed countries. As a result, the high pricing of testing kits will prevent the market from expanding.
Additionally, the projected expansion of the global at-home testing market is anticipated to be hampered by the rising number of product recalls of self-testing kits by regulatory bodies like the USA FDA. There are multiple pieces of evidence of such recalls in the market.
These variables in total propose an adverse consequence on the formative development of the at-home testing market.
The USA dominates the North American region with a total market share of about 91.6 % in 2021 and is expected to continue the same through the forecast period.
This is because the USA market is highly fragmented with many new market players trying to promote their products, launch multiple innovative products, high prevalence of certain chronic and infectious diseases, and high awareness among consumers. The USA Federal government has also introduced a lot of schemes and awareness programs for the higher adoption of self-test kits and to get tested.
The rate of obese people living in the USA is also high, and high diabetic awareness has increased the adoption of continuous blood glucose monitors.
China is expected to display growth at a CAGR of 5.2% in the East Asia market over the forecast period.
The market for self-testing devices in China is increasing. Medical chemistry, immunoassay, coagulation, hematology, and microbiology are all highly sought-after fields. Another indicator of potential opportunities in China is the employment of in-house manufactured devices.
Because the country's economy is intricately linked to its healthcare system, the market is expected to grow in the future years. The Chinese government's expanding initiatives to promote the healthcare sector, which is another factor fuelling demand for self-testing kits.
The United Kingdom holds the largest market share in Europe at-home testing market in 2021 generating revenue of close to US$ 386.2 million and is expected to grow with a CAGR of 2.2% during the forecasted period.
People's regular habit of visiting clinic have been replaced with the awareness of self-test kits in the market. Self-testing kits are readily accessible at pharmacies, and obtaining them has never been simpler. Numerous healthcare organizations are entering this market since they quickly produce self-test kits.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Digital monitoring systems held a market share of around 46.7% in the global market in 2021, and the segment is expected to grow with a CAGR of 4.4% during the forecast period.
The ability of sensors to record precise data for predicted, planned, and emergency maintenance adds cost efficiencies to digital monitoring. Furthermore, they are easy to use as they have stronger compliance as all the medical data is automatically stored in the system. Hence, they have a greater preference, and the market is set to expand as a result.
Blood glucose testing has shown increased demand with a market share of 70.4% globally in 2021 and is expected to grow with a CAGR of 3.8% during the forecast period.
Blood glucose monitors are widely used for home tests as they provide a timely and dependable assessment of an individual's blood glucose concentrations in order to make appropriate food, exercise, and medication decisions. In addition, they are handy, can be used for a prolonged time, and help to keep sugar levels in check.
Blood is widely used as a sample for at-home testing kits as it evaluates the overall health, checks the function of specific organs such as the liver and kidneys, and screens for genetic diseases. The segment holds the largest market share with revenue of nearly US$ 5.1 billion in the global market and is expected to grow with a CAGR of 3.8% in the forecast period.
Drug stores hold the highest market share value of 49.6% during the year 2021 globally.
This is because most drug stores and local pharmacies have multiple options for home test kits. They are easily accessible, and consumers can select from a wide range of products. The presence of established drug store chains and supermarket chains like Walmart have even increased the adoption rate. Such chains are engaging in collaborations with at-home testing kit manufacturers to promote their products.
The market is highly fragmented and there are many companies operating and launching new products in the market. Key Players such as Abbott Diagnostics, and Quest Direct (Quest Diagnostics), are adopting expansion of their business in the untapped markets and acquisition of smaller companies to promote their products.
In order to meet consumer demand and grow their customer base, other companies are also following their footsteps to do mergers and acquisitions, partnerships and collaborations, and new product launches.
The following are examples of key development strategies used by industry players in the at-home testing market:
Similarly, recent developments related to companies manufacturing at-home testing products, have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ billion for Value, Units for Volume |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa. |
Key Market Segments Covered | Product, Application, Sample, Distribution Channel, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global at-home testing market is estimated to be worth US$ 7.1 billion in 2022 and is set to expand 1.5X over the next ten years.
The at-home testing market is expected to reach US$ 10.5 billion by the end of 2032, with sales revenue expected to register 4.0% CAGR.
The expanding research and development of the at-home testing products, increased awareness about health and hygiene, HIV health awareness, immense advertising, and increasing number of infectious diseases, are the key trends being witnessed in this market.
The USA, Japan, China, The United Kingdom, and France are the top five countries and are expected to drive demand for the at-home testing kits market.
North America is one of the key markets for at-home testing, with the USA accounting for around 91.6% of the North American at-home testing market in the year 2021.
Demand for at-home testing in Europe is expected to register a growth of 4.1% CAGR over the next ten years.
The USA, China, and the United Kingdom are the key producers of at-home testing products.
Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA, Everlywell, and LetsgetChecked, are the key players within the market.
The Japan market held a share of about 43.8% in the East Asia at-home testing market in 2021.
Digital monitoring system is the major product segment in the global at-home testing market with a share of 46.7% in the year 2021.
1. Executive Summary | At-Home Testing Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 4.3. PESTLE Analysis 4.4. Porter’s Analysis 4.5. Regulatory Scenario 4.6. Reimbursement Scenario 4.7. Sample Collection Analysis, By Country 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Spending Outlook 5.1.3. Global In-Vitro Diagnostics Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Awareness about Self Testing Kits 5.2.2. Transition from Lab-based Screening to Disposable Devices 5.2.3. Easy Availability & Government Recommendations 5.2.4. Rising Per Capita Disposable Income 5.2.5. Collaborations With e-Commerce Partners 5.2.6. Increasing Adoption of Dual Capability Tests 5.2.7. Regulatory Scenario 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By Sample 6.1.4. By Distribution Channel 6.1.5. By Region 6.2. 2021 Market Scenario 7. Global Market Demand in Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2015 to 2021 7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis by Product 8.2. Pricing Break Up 8.2.1. Manufacturer Level 8.2.2. Distributor Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ million) Analysis 2015 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ million) Analysis 2015 to 2021 9.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) Analysis by Product, 2015 to 2021 10.3. Current and Future Market Size (US$ million) Analysis and Forecast by Product, 2022 to 2032 10.3.1. Digital Monitoring Instruments 10.3.2. Cassettes 10.3.3. Midstreams 10.3.4. Strips 10.3.5. Cups 10.3.6. Dip Cards 10.3.7. Test Panels 10.3.8. Sample collection kits 10.3.9. Others 10.4. Market Attractiveness Analysis by Product 11. Global Market Analysis, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Application, 2015 to 2021 11.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Application, 2022 to 2032 11.3.1. Blood Glucose Testing 11.3.2. Pregnancy & Fertility Testing 11.3.3. Cancer Testing 11.3.4. Search and Rescue 11.3.5. STD/ STI Testing 11.3.5.1. Chlamydia and Gonorrhea 11.3.5.2. HIV Testing 11.3.6. Cholesterol Testing 11.3.7. Testosterone 11.3.8. Drug of Abuse Testing 11.3.9. Cholesterol Testing 11.3.10. Thyroid Testing 11.3.11. Others 11.4. Market Attractiveness Analysis by Application 12. Global Market Analysis, By Sample 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ million) Analysis by Sample, 2015 to 2021 12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Sample, 2022 to 2032 12.3.1. Urine 12.3.2. Blood 12.3.3. Saliva 12.3.4. Stool 12.3.5. Vaginal Swab 12.3.6. Semen 12.4. Market Attractiveness Analysis by Sample 13. Global Market Analysis, By Distribution Channel 13.1. Introduction 13.2. Historical Market Size (US$ million) Analysis by Distribution Channel, 2015 to 2021 13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Distribution Channel, 2022 to 2032 13.3.1. Drug Stores 13.3.2. Hospital Pharmacies 13.3.3. Online Channels 13.4. Market Attractiveness Analysis by Distribution Channel 14. Global Market Analysis, by Region 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Region, 2015 to 2021 14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. South Asia 14.3.5. East Asia 14.3.6. Oceania 14.3.7. Middle East & Africa 14.4. Market Attractiveness Analysis By Region 15. North America Market Analysis 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. The USA 15.3.1.2. Canada 15.3.2. By Product 15.3.3. By Application 15.3.4. By Sample 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Product 15.4.2. By Application 15.4.3. By Sample 15.4.4. By Distribution Channel 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country-Level Analysis & Forecast 15.8.1. The USA Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Application 15.8.1.2.3. By Sample 15.8.1.2.4. By Distribution Channel 15.8.2. Canada Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Application 15.8.2.2.3. By Sample 15.8.2.2.4. By Distribution Channel 16. Latin America Market Analysis 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Mexico 16.3.1.3. Argentina 16.3.1.4. Rest of Latin America 16.3.2. By Product 16.3.3. By Application 16.3.4. By Sample 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Product 16.4.2. By Application 16.4.3. By Sample 16.4.4. By Distribution Channel 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country-Level Analysis & Forecast 16.8.1. Brazil Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Application 16.8.1.2.3. By Sample 16.8.1.2.4. By Distribution Channel 16.8.2. Mexico Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Application 16.8.2.2.3. By Sample 16.8.2.2.4. By Distribution Channel 16.8.3. Argentina Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Application 16.8.3.2.3. By Sample 16.8.3.2.4. By Distribution Channel 17. Europe Market Analysis 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. Germany 17.3.1.2. Italy 17.3.1.3. France 17.3.1.4. The United Kingdom 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Russia 17.3.1.8. Rest of Europe 17.3.2. By Product 17.3.3. By Application 17.3.4. By Sample 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Product 17.4.2. By Application 17.4.3. By Sample 17.4.4. By Distribution Channel 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country-Level Analysis & Forecast 17.8.1. Germany Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Application 17.8.1.2.3. By Sample 17.8.1.2.4. By Distribution Channel 17.8.2. Italy Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Application 17.8.2.2.3. By Sample 17.8.2.2.4. By Distribution Channel 17.8.3. France Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Application 17.8.3.2.3. By Sample 17.8.3.2.4. By Distribution Channel 17.8.4. The United Kingdom Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Application 17.8.4.2.3. By Sample 17.8.4.2.4. By Distribution Channel 17.8.5. Spain Market Analysis 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Application 17.8.5.2.3. By Sample 17.8.5.2.4. By Distribution Channel 17.8.6. BENELUX Market Analysis 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Application 17.8.6.2.3. By Sample 17.8.6.2.4. By Distribution Channel 17.8.7. Russia Market Analysis 17.8.7.1. Introduction 17.8.7.2. Market Analysis and Forecast by Market Taxonomy 17.8.7.2.1. By Product 17.8.7.2.2. By Application 17.8.7.2.3. By Sample 17.8.7.2.4. By Distribution Channel 18. South Asia Market Analysis 18.1. Introduction 18.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Indonesia 18.3.1.3. Malaysia 18.3.1.4. Thailand 18.3.1.5. Vietnam 18.3.1.6. Philippines 18.3.1.7. Rest of South Asia 18.3.2. By Product 18.3.3. By Application 18.3.4. By Sample 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Product 18.4.2. By Application 18.4.3. By Sample 18.4.4. By Distribution Channel 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country-Level Analysis & Forecast 18.8.1. India Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Application 18.8.1.2.3. By Sample 18.8.1.2.4. By Distribution Channel 18.8.2. Indonesia Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Application 18.8.2.2.3. By Sample 18.8.2.2.4. By Distribution Channel 18.8.3. Malaysia Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Application 18.8.3.2.3. By Sample 18.8.3.2.4. By Distribution Channel 18.8.4. Thailand Market Analysis 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast by Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By Application 18.8.4.2.3. By Sample 18.8.4.2.4. By Distribution Channel 18.8.5. Vietnam Market Analysis 18.8.5.1. Introduction 18.8.5.2. Market Analysis and Forecast by Market Taxonomy 18.8.5.2.1. By Product 18.8.5.2.2. By Application 18.8.5.2.3. By Sample 18.8.5.2.4. By Distribution Channel 18.8.6. Philippines Market Analysis 18.8.6.1. Introduction 18.8.6.2. Market Analysis and Forecast by Market Taxonomy 18.8.6.2.1. By Product 18.8.6.2.2. By Application 18.8.6.2.3. By Sample 18.8.6.2.4. By Distribution Channel 19. East Asia Market Analysis 19.1. Introduction 19.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. China 19.3.1.2. Japan 19.3.1.3. South Korea 19.3.2. By Product 19.3.3. By Application 19.3.4. By Sample 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Product 19.4.2. By Application 19.4.3. By Sample 19.4.4. By Distribution Channel 19.5. Market Trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country-Level Analysis & Forecast 19.8.1. China Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Application 19.8.1.2.3. By Sample 19.8.1.2.4. By Distribution Channel 19.8.2. Japan Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Application 19.8.2.2.3. By Sample 19.8.2.2.4. By Distribution Channel 19.8.3. South Korea Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Application 19.8.3.2.3. By Sample 19.8.3.2.4. By Distribution Channel 20. Oceania Market Analysis 20.1. Introduction 20.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 20.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Product 20.3.3. By Application 20.3.4. By Sample 20.3.5. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Product 20.4.2. By Application 20.4.3. By Sample 20.4.4. By Distribution Channel 20.5. Market Trends 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country-Level Analysis & Forecast 20.8.1. Australia Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Application 20.8.1.2.3. By Sample 20.8.1.2.4. By Distribution Channel 20.8.2. New Zealand Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Application 20.8.2.2.3. By Sample 20.8.2.2.4. By Distribution Channel 21. Middle East and Africa Market Analysis 21.1. Introduction 21.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 21.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Turkey 21.3.1.3. North Africa 21.3.1.4. South Africa 21.3.1.5. Rest of Middle East and Africa 21.3.2. By Product 21.3.3. By Application 21.3.4. By Sample 21.3.5. By Distribution Channel 21.4. Market Attractiveness Analysis 21.4.1. By Product 21.4.2. By Application 21.4.3. By Sample 21.4.4. By Distribution Channel 21.5. Market Trends 21.6. Key Market Participants - Intensity Mapping 21.7. Drivers and Restraints - Impact Analysis 21.8. Country-Level Analysis & Forecast 21.8.1. GCC Countries Market Analysis 21.8.1.1. Introduction 21.8.1.2. Market Analysis and Forecast by Market Taxonomy 21.8.1.2.1. By Product 21.8.1.2.2. By Application 21.8.1.2.3. By Sample 21.8.1.2.4. By Distribution Channel 21.8.2. Turkey Market Analysis 21.8.2.1. Introduction 21.8.2.2. Market Analysis and Forecast by Market Taxonomy 21.8.2.2.1. By Product 21.8.2.2.2. By Application 21.8.2.2.3. By Sample 21.8.2.2.4. By Distribution Channel 21.8.3. North Africa Market Analysis 21.8.3.1. Introduction 21.8.3.2. Market Analysis and Forecast by Market Taxonomy 21.8.3.2.1. By Product 21.8.3.2.2. By Application 21.8.3.2.3. By Sample 21.8.3.2.4. By Distribution Channel 21.8.4. South Africa Market Analysis 21.8.4.1. Introduction 21.8.4.2. Market Analysis and Forecast by Market Taxonomy 21.8.4.2.1. By Product 21.8.4.2.2. By Application 21.8.4.2.3. By Sample 21.8.4.2.4. By Distribution Channel 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 22.3.1. Regional Footprint by Players 22.3.2. Product Footprint by Players 22.3.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. Abbott 23.3.1.1. Overview 23.3.1.2. Product Portfolio 23.3.1.3. Sales Footprint 23.3.1.4. Key Financials 23.3.1.5. SWOT Analysis 23.3.1.6. Strategy Overview 23.3.1.6.1. Marketing Strategy 23.3.1.6.2. Product strategy 23.3.1.6.3. Channel Strategy 23.3.2. Becton, Dickinson and Company. 23.3.2.1. Overview 23.3.2.2. Product Portfolio 23.3.2.3. Sales Footprint 23.3.2.4. Key Financials 23.3.2.5. SWOT Analysis 23.3.2.6. Strategy Overview 23.3.2.6.1. Marketing Strategy 23.3.2.6.2. Product strategy 23.3.2.6.3. Channel Strategy 23.3.3. ACCESS BIO 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. Sales Footprint 23.3.3.4. Key Financials 23.3.3.5. SWOT Analysis 23.3.3.6. Strategy Overview 23.3.3.6.1. Marketing Strategy 23.3.3.6.2. Product strategy 23.3.3.6.3. Channel Strategy 23.3.4. CELLTRION INC. 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. Sales Footprint 23.3.4.4. Key Financials 23.3.4.5. SWOT Analysis 23.3.4.6. Strategy Overview 23.3.4.6.1. Marketing Strategy 23.3.4.6.2. Product strategy 23.3.4.6.3. Channel Strategy 23.3.5. Siemens Healthcare GmbH 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. Sales Footprint 23.3.5.4. Key Financials 23.3.5.5. SWOT Analysis 23.3.5.6. Strategy Overview 23.3.5.6.1. Marketing Strategy 23.3.5.6.2. Product strategy 23.3.5.6.3. Channel Strategy 23.3.6. ACON Laboratories Inc. 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. Sales Footprint 23.3.6.4. Key Financials 23.3.6.5. SWOT Analysis 23.3.6.6. Strategy Overview 23.3.6.6.1. Marketing Strategy 23.3.6.6.2. Product Strategy 23.3.6.6.3. Channel Strategy 23.3.7. ARKRAY, Inc 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. Sales Footprint 23.3.7.4. Key Financials 23.3.7.5. SWOT Analysis 23.3.7.6. Strategy Overview 23.3.7.6.1. Marketing Strategy 23.3.7.6.2. Product Strategy 23.3.7.6.3. Channel Strategy 23.3.8. F. Hoffmann-La Roche Ltd. 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. Sales Footprint 23.3.8.4. Key Financials 23.3.8.5. SWOT Analysis 23.3.8.6. Strategy Overview 23.3.8.6.1. Marketing Strategy 23.3.8.6.2. Product strategy 23.3.8.6.3. Channel Strategy 23.3.9. OraSure, Technologies Inc. 23.3.9.1. Overview 23.3.9.2. Product Portfolio 23.3.9.3. Sales Footprint 23.3.9.4. Key Financials 23.3.9.5. SWOT Analysis 23.3.9.6. Strategy Overview 23.3.9.6.1. Marketing Strategy 23.3.9.6.2. Product strategy 23.3.9.6.3. Channel Strategy 23.3.10. Quest Diagnostics 23.3.10.1. Overview 23.3.10.2. Product Portfolio 23.3.10.3. Sales Footprint 23.3.10.4. Key Financials 23.3.10.5. SWOT Analysis 23.3.10.6. Strategy Overview 23.3.10.6.1. Marketing Strategy 23.3.10.6.2. Product strategy 23.3.10.6.3. Channel Strategy 23.3.11. Bionime Corporation 23.3.11.1. Overview 23.3.11.2. Product Portfolio 23.3.11.3. Sales Footprint 23.3.11.4. Key Financials 23.3.11.5. SWOT Analysis 23.3.11.6. Strategy Overview 23.3.11.6.1. Marketing Strategy 23.3.11.6.2. Product strategy 23.3.11.6.3. Channel Strategy 23.3.12. Btnx Inc. 23.3.12.1. Overview 23.3.12.2. Product Portfolio 23.3.12.3. Sales Footprint 23.3.12.4. Key Financials 23.3.12.5. SWOT Analysis 23.3.12.6. Strategy Overview 23.3.12.6.1. Marketing Strategy 23.3.12.6.2. Product strategy 23.3.12.6.3. Channel Strategy 23.3.13. iHealth Labs Inc. 23.3.13.1. Overview 23.3.13.2. Product Portfolio 23.3.13.3. Sales Footprint 23.3.13.4. Key Financials 23.3.13.5. SWOT Analysis 23.3.13.6. Strategy Overview 23.3.13.6.1. Marketing Strategy 23.3.13.6.2. Product strategy 23.3.13.6.3. Channel Strategy 23.3.14. InBios International, Inc. USA. 23.3.14.1. Overview 23.3.14.2. Product Portfolio 23.3.14.3. Sales Footprint 23.3.14.4. Key Financials 23.3.14.5. SWOT Analysis 23.3.14.6. Strategy Overview 23.3.14.6.1. Marketing Strategy 23.3.14.6.2. Product strategy 23.3.14.6.3. Channel Strategy 23.3.15. Everlywell 23.3.15.1. Overview 23.3.15.2. Product Portfolio 23.3.15.3. Sales Footprint 23.3.15.4. Key Financials 23.3.15.5. SWOT Analysis 23.3.15.6. Strategy Overview 23.3.15.6.1. Marketing Strategy 23.3.15.6.2. Product strategy 23.3.15.6.3. Channel Strategy 23.3.16. LetsgetChecked 23.3.16.1. Overview 23.3.16.2. Product Portfolio 23.3.16.3. Sales Footprint 23.3.16.4. Key Financials 23.3.16.5. SWOT Analysis 23.3.16.6. Strategy Overview 23.3.16.6.1. Marketing Strategy 23.3.16.6.2. Product strategy 23.3.16.6.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Healthcare
June 2023
REP-GB-6108
342 pages
Explore Healthcare Insights
View Reports